Hakin-1
/ University of A Coruña
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 28, 2022
Targeting protein degradation as a novel cancer therapeutic strategy: from research to innovation
(EACR 2022)
- "Moreover, Hakin-1 inhibits tumour growth in xenografted mice This represents an important step forward in further development of an effective therapeutic drug that would prevent or inhibit carcinoma tumour progression. Conclusion As Hakin-1 exerts an antitumor activity in colon cancer cells, by inhibiting proliferation, colony formation, migration and invasion, accompanied by an elevation of E-cadherin expression at cell-cell contacts, we will discuss the potential of the project to advance into a novel therapeutic strategies to halt cancer."
Colon Cancer • Colorectal Cancer • Gastrointestinal Cancer • Oncology • Solid Tumor • Targeted Protein Degradation • CDH1
1 to 1
Of
1
Go to page
1